This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Suggested Reading
Borrello MG. RET activation by germline MEN-2A and MEN-2B mutations. Oncogene 1995;11:2419.
Donis-Keller H, Dou S, Chi D, et al. Mutations in the RET protooncogene are associated with MEN2A and FMTC. Hum Mol Genet 1993;2:851–856.
Duh QY, Sancho JJ, Greenspan FS, et al. Medullary thyroid carcinoma: the need for early diagnosis and total thyroidectomy. Arch Surg 1989;124:1206–1210.
Forrest CH, et al. Medullary carcinoma of the thyroid: accuracy of diagnosis of fine-needle aspiration cytology. Cancer (Phila) 1998; 84:295.
Dennis Frisman. Immunoquery: Immunohistochemistry literature database program. n.d. http://www.immunoquery.com (January 15, 2004).
Kaserer K, et al. C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin. Am J Surg Pathol 1998;22:722.
Mulligan LM, et al. Genetic events in tumor initiation and progression in MEN type 2. Genes Chromosomes Cancer 1993;6:166.
Randolph GW, De la Cruz A, Faquin WC. Medullary carcinoma of the thyroid. In: Pellitteri PK, McCaffrey TV (eds) Endocrine surgery of the head and neck. Clifton Park, NY: Thomson Delmar Learning, 2003:167–182.
Vierhopper H, et al. Routine measurement of plasma calcitonin in nodular thyroid diseases. J Clin Endocrinol Metab 1997;82:1589.
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
(2005). Medullary Thyroid Carcinoma. In: Thyroid Cytopathology. Essentials in Cytopathology, vol 1. Springer, New York, NY. https://doi.org/10.1007/0-387-27657-2_10
Download citation
DOI: https://doi.org/10.1007/0-387-27657-2_10
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-23304-8
Online ISBN: 978-0-387-27657-1
eBook Packages: MedicineMedicine (R0)